CM
MESO

Caption Management’s Mesoblast MESO Stock Holding History

Caption Management’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,800
Closed -$64K – 1267
2020
Q4 		$64K Buy
+3,800
New +$93.5K ﹤0.01% 908

Other funds holding MESO

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PM
Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
PCM
Princeton Capital Management Red Bank, New Jersey $367M AUM 45.24% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JAMONY
Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return

Caption Management's MESO Position: Q1 2021 in Review

Caption Management sold out of Mesoblast (MESO) in Q1 2021, closing a stake of 3,800 shares — an estimated $64K sold.

Caption Management first reported a position in MESO in Q4 2020 and held it in 1 quarter. The position peaked at $64K in Q4 2020. 52 funds tracked by Wall St. Rank hold MESO as of Q1 2021.

  • Caption Management reported no remaining Mesoblast position as of Q1 2021 after selling out during the quarter.
  • Caption Management sold 3,800 Mesoblast shares in Q1 2021, an estimated $64K.
  • Caption Management first reported a position in Mesoblast in Q4 2020 and held it in 1 quarter.
  • Caption Management's Mesoblast position peaked at $64K in Q4 2020.
  • 52 funds tracked by Wall St. Rank held Mesoblast as of Q1 2021.

Based on Caption Management's 13F filing for Q1 2021, filed 17 May 2021.